| 1. | Merck Frosst Canada - Endocrine Disorders |
| | Possible therapeutic applications for such a medication extend well beyond diabetes, into the treatment of obesity, the root cause of type 2 diabetes and many other chronic disorders including the most important killer of them all : cardiovascular disease.... |
| |
| 2. | Merck Frosst Canada - Sales and Marketing |
| | Whether they are discussing a new initiative to help physicians identify patients at risk of cardiovascular disease or new data on the treatment of early-stage osteoporosis, sales representatives play an important role in communicating the benefits of Merck Frosst medicines.... |
| |
| 3. | Merck Frosst Canada - Partners |
| | For more than 100 years, the names Merck and Frosst have been inextricably linked to many advances-in the treatment of infectious diseases and pain and inflammation, for breakthroughs in immunization and vaccines, in the treatment of cardiovascular diseases, in mitigating the effects of glaucoma and osteoporosis and in controlling the symptoms of asthma.... |
| |
| 4. | Merck Frosst Canada - Partners |
| | Cardiovascular Diseases... |
| |
| 5. | Merck Frosst Canada - Our History |
| | For more than 100 years, the names Merck and Frosst have been inextricably linked to many advances - in the treatment of infectious diseases, pain and inflammation, for breakthroughs in immunization and vaccines, in the treatment of cardiovascular diseases, in mitigating the effects of glaucoma and osteoporosis and in controlling the symptoms of asthma.... |
| |
| 6. | Merck Frosst Canada - Health Policies & Programs |
| | Patient Health ManagementMerck Frosst is a partner in a number of across Canada aimed at improving health care management and delivery in a wide variety of therapeutic areas, including asthma, cardiovascular disease, diabetes and osteoporosis.. PHM is a disease management approach to healthcare that seeks to improve practice patterns and patient health outcomes.. |
| |
| 7. | Merck Frosst Canada - Health Policies & Programs |
| | Designed to measure and improve the quality of care provided to Nova Scotians with cardiovascular disease.... |
| |
